Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo

Publisher： John Wiley & Sons Inc

E-ISSN： 2047-9980|4|7|JAHA.115.002146-JAHA.115.002146

ISSN： 2047-9980

Source： JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.4, Iss.7, 2015-07, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 5, 2015-05 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rapid Progression of Unilateral Moyamoya Disease in a Patient with a Family History and an RNF213 Risk Variant

By  

Cerebrovascular Diseases, Vol. 36, Iss. 2, 2013-09 ,pp. : 155-157

Karger

Access to resources Recommend Favorite

Levamisole Inhibits Angiogenesis in vitro and Tumor Growth in vivo

By Friis Tina  

Angiogenesis, Vol. 8, Iss. 1, 2005-03 ,pp. : 25-34

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of Direct and Indirect Cerebral Revascularization for the Treatment of European Patients with Moyamoya Disease

By  

Cerebrovascular Diseases, Vol. 32, Iss. 4, 2011-09 ,pp. : 361-369

Karger

Access to resources Recommend Favorite

Moyamoya Disease: Collateralization Is Everything

By  

Cerebrovascular Diseases, Vol. 28, Iss. 3, 2009-07 ,pp. : 258-258

Karger

Access to resources Recommend Favorite